COVID-19 and return to campus information.
University of California, Riverside
A UC Riverside-led study, funded by Merck, is set to find out
UC Riverside study focused on how HIV mutates to escape the immune system
Research could lead to the design of new and better treatments to fight disease
Total funding of three grants exceeds $1.2 million
UC Riverside-led study finds persons with any HPV type, more than one HPV type, or high-risk HPV are more likely to test HIV positive
UC Riverside-led study in Southern California finds stigma, risk perceptions, and cost among major factors contributing to adults’ willingness to get HIV tested